The Low-Dose (7.5 mg/day) Pioglitazone Therapy

Pioglitazone is one of thiazolidinedione derivatives, which stimulates nuclear peroxisome proliferator-activated receptor gamma and improves glucose and lipid metabolism and insulin sensitivity. A recent systematic review and meta-analysis showed that pioglitazone therapy was associated with a lower...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanai, Hidekatsu, Adachi, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593428/
https://www.ncbi.nlm.nih.gov/pubmed/28912917
http://dx.doi.org/10.14740/jocmr3144w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593428/
https://www.ncbi.nlm.nih.gov/pubmed/28912917
http://dx.doi.org/10.14740/jocmr3144w

Ejemplares similares